FORT COLLINS, Colo., Oct. 7 /PRNewswire/ -- A study published in the scientific journal Nature examining embryonic stem cell self-renewal, reported that InVitria's (http://www.InVitria.com) Cellastim (recombinant human serum albumin) was an effective replacement to bovine serum albumin in ES-cell culture.
The article entitled, "The ground state of embryonic stem cell self-renewal," disclosed that researchers used Cellastim as a recombinant albumin in place of animal-derived serum to eliminate contaminants in the cell culture. The Cellastim was a contributing factor in the enhancement of bulk passaging and clonal propagation (1).
"This study further supports the use of InVitria's Cellastim as an enhancement to cell culture media," said InVitria President Scott Deeter. "Cellastim is the only supplement available that not only improves cell culture performance, but does so while maintaining a defined and animal free media."
About InVitria (http://www.InVitria.com)
InVitria has developed cell culture ingredients that enhance productivity, safety and time to market for companies in the biopharmaceutical, cell culture, regenerative medicine, life science research and diagnostics industry. Cellastim is used to enhance cell growth and productivity. It is animal component free and has been used as a cell culture ingredient in regenerative medicine, mammalian cell culture media, stem cell media and primary cell media. (See http://www.Cellastim.com)
For more information about the InVitria line of products, please e-mail info@InVitria.com or call 1-800-916-8311.
(1) Ying, Q.L.et al. The ground state of embryonic stem cell self- renewal. Nature 453, 519-524 (May 2008).
Copyright©2008 PR Newswire.
All rights reserved